IKE Tech Submits PMTA and TPMF Applications for Blockchain-Based Age Verification Component to FDA

May.06.2025
IKE Tech Submits PMTA and TPMF Applications for Blockchain-Based Age Verification Component to FDA
IKE Tech LLC announced that it has submitted a Premarket Tobacco Application (PMTA) and a Tobacco Product Master File (TPMF) to the U.S. Food and Drug Administration (FDA). The submitted products include a blockchain-based Bluetooth Low Energy (BLE) system-on-chip and a smartphone identity and age verification application.

Key points:

 

1.IKE Tech LLC announced on May 1st that they have submitted their blockchain-based Bluetooth Low Energy (BLE) system chip and smartphone identity and age verification application PMTA and TPMF to the United States FDA.

 

2.For the first time, the company has submitted a full PMTA application for an independent, scalable age verification component, which can provide real-time, continuous age verification at points of use in electronic nicotine delivery systems (ENDS).

 

3.Company background: IKE Tech LLC is a joint venture composed of Ispire Technology Inc., Touch Point Worldwide Inc. (operating under the name Berify), and Chemular Inc., committed to innovating identity and age verification (IAV) technology solutions.


IKE Tech LLC announced on May 1 that it has submitted a premarket tobacco product application (PMTA) and a tobacco product master file (TPMF) to the US Food and Drug Administration (FDA) for its blockchain-based Bluetooth Low Energy (BLE) system chip and smartphone identity and age verification application components.

 

The company stated, "This is the first time a complete PMTA application has been submitted for an independent, scalable age verification component that can provide real-time, continuous age verification at the point of use for electronic nicotine delivery systems (ENDS). The IKE system is designed to achieve universal integration with all ENDS devices, utilizing a unique blockchain-based tokenization technology to further ensure user privacy and security.

 

IKE Tech stated in a multi-center human factor validation study submitted to the PMTA that their system has demonstrated 100% effectiveness in preventing individuals under 21 from activating the device. The company has formally requested an expedited review of their application, emphasizing the potential of the system in enhancing public health.

 

Ispire CEO Michael Wang stated, "Ispire will not only benefit from the commercial sales of this component, but also from the rights to integrate this technology into our own devices - allowing us to lead in compliant innovation and unlock new revenue opportunities.

 

John Patterson, President of IKE Tech, stated, "This is a significant milestone for IKE Tech and the ENDS category. We are not just building technology, we are laying the groundwork for a new regulatory framework to provide FDA and manufacturers with powerful tools to protect public health and ensure that only adults use e-cigarette products. By integrating validated and scalable age verification technology into ENDS devices, the industry now has a real opportunity to completely eliminate the issue of underage e-cigarette use.

 

Unlike existing solutions that allow permanent access after disposable verification at the time of purchase, IKE's system requires continuous verification to maintain device access. Human verification research shows that 91% of users (aged between 18 and 67) find the app to be "very easy" or "extremely easy" to use, with a user error rate of less than 0.8%.

 

IKE Tech LLC is a joint venture formed by three technology and research companies - Ispire Technology Inc., Touch Point Worldwide Inc. (operating under the name Berify), and Chemular Inc. - dedicated to innovating identity and age verification (IAV) technology solutions.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
UK consumer goods group Supreme said its vaping revenue rose 15% to £148.1 million in the year to March 31, 2026, despite the UK disposable vape ban taking effect during the period, while the company identified the Vaping Products Duty due in October as the next major industry milestone.
Regulations
Jul.03 by 2Firsts Perspectives
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
Based on public records reviewed by 2Firsts, this is the first time China’s State Tobacco Monopoly Administration has publicly announced regulatory talks with an e-cigarette company.
Jul.29
U.S. House Defense Bill Includes Pilot Review of Vapes, Nicotine Pouches and Heated Tobacco for Military Smokers
U.S. House Defense Bill Includes Pilot Review of Vapes, Nicotine Pouches and Heated Tobacco for Military Smokers
On July 23, 2026, the U.S. House of Representatives passed its version of the Fiscal Year 2027 National Defense Authorization Act (NDAA), which includes Section 707 provisions requiring the Department of Defense to evaluate tobacco use and nicotine alternatives among military personnel. The pilot program would examine products including vapes, nicotine pouches and heated tobacco products, primarily among active-duty service members who continue using combustible tobacco. The provision is a policy evaluation effort, not an authorization for military vaping promotion or a ban on vape products.
Jul.28
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
Philip Morris International’s second-quarter net revenues rose 10.4% to a record $11.19 billion, as heated tobacco and e-vapor expanded across international markets. IQOS remained the main smoke-free growth engine, while VEEV shipments jumped 55.1%. In the United States, however, ZYN shipments increased just 1.8% and consumer offtake was broadly flat to slightly higher. Cigarette volumes also rose, showing that PMI’s transformation is advancing, but growth is becoming increasingly uneven across categories and markets.
PMI
Jul.22
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
EU Tobacco Rules Face Pushback as Analysis Says 90% of Consultation Responses Raised Objections
An analysis by We Are Innovation says more than 90% of over 82,000 responses to the European Commission’s public consultation on the Tobacco Products Directive revision raised at least one substantial objection to the proposed regulatory direction.
Jul.13